A carregar...
Pharmacovigilance of biosimilars – Why is it different from generics and innovator biologics?
Biosimilars are being marketed in India since 2000. Like biologics, biosimilars have a large size, complex structure, and complicated manufacturing process, and they are produced in a living organism. It requires specialized delivery devices for administration and needs tighter temperature control t...
Na minha lista:
| Publicado no: | J Postgrad Med |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wolters Kluwer - Medknow
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6813686/ https://ncbi.nlm.nih.gov/pubmed/31571620 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/jpgm.JPGM_109_19 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|